Is Hypertrophic Cardiomyopathy Hereditary? | Inciteful Med

Hypertrophic cardiomyopathy (HCM) is often a genetic condition, but inheriting the gene does not mean your children will definitely develop the physical disease. HCM is predominantly passed down in an autosomal dominant pattern, meaning it affects males and females equally, and each child of someone with HCM has a 50% chance of inheriting the genetic mutation ^[1][2]. However, due to a concept known as incomplete penetrance, a person can carry the genetic mutation without ever developing the thickened heart muscle characteristic of HCM ^[3][4]. Because the disease can develop over time, doctors use a structured process called cascade screening to test your close family members and monitor them appropriately.

Understanding How HCM is Inherited

When a condition is autosomal dominant, a single copy of the mutated gene (from either parent) is enough to cause the condition ^[1]. This means that for every pregnancy, there is a 1 in 2 chance the child will inherit the mutation, regardless of their sex.

The majority of these genetic mutations occur in genes responsible for building the heart’s sarcomeres, which are the tiny structures that allow the heart muscle to contract and pump blood ^[1][5].

The Difference Between the Gene and the Disease

Understanding the genetics of HCM requires looking at two distinct factors: the gene you carry and how that gene actually affects your body.

• Can you have the gene but not the disease? Yes. This is called incomplete penetrance. Having an HCM mutation is only one piece of the puzzle. Many people who inherit an HCM mutation will have completely normal-looking hearts for their entire lives, a phenomenon where the physical disease never fully “penetrates” or develops ^[6][4].
• Will my child’s HCM be as severe as mine? Not necessarily. This is known as variable expressivity. Even within the same family, individuals with the exact same genetic mutation can experience completely different symptoms, ages of onset, and levels of disease severity ^[7][8]. The fact that you have a specific severity of HCM does not predict that your child will have the same severity. Other genetic factors, as well as environmental factors like age, play a role in how the disease manifests ^[7][8].

Cascade Screening: Protecting Your Family

Because HCM runs in families, medical guidelines recommend that all first-degree relatives (parents, siblings, and children) of someone diagnosed with HCM undergo evaluation ^[9][10]. The most effective way to do this is through cascade screening, which unfolds in a step-by-step manner. Note: It is highly recommended to work with a specialized cardiovascular genetic counselor to navigate the emotional, ethical, and insurance implications of testing your family.

1. Genetic Testing for the Diagnosed Patient: The process usually begins with you (the “index patient”). If a blood or saliva test can identify the exact genetic mutation causing your HCM, that mutation becomes the “key” to testing the rest of your family ^[11][12].
2. Targeted Genetic Testing for Relatives: Once your specific mutation is known to be the definite cause (a “pathogenic” mutation), your first-degree relatives can be tested for that exact gene—often using a simple, painless saliva swab rather than a blood draw ^[11][4].
   • If they do not carry the gene: As long as your mutation is definitively known to cause HCM, relatives who test negative can generally be discharged from regular heart screening.
   • If they do carry the gene: They are considered “genotype-positive.” Even if their heart currently looks completely normal, they will require ongoing monitoring by a cardiologist, typically involving an EKG and echocardiogram every 1 to 3 years depending on their age ^[13][2]. Generally, kids with the gene but normal hearts can still be active and participate in recess and sports, but this must be discussed with their pediatric cardiologist.
3. Clinical Screening (Imaging and EKGs): If your genetic testing is “negative” or only shows a variant of uncertain significance, your relatives will still need physical clinical screening ^[9][10]. Why? Because science has not yet discovered every single gene that causes HCM. A negative test for you does not guarantee your children won’t develop it. They will need an electrocardiogram (EKG/ECG) and an echocardiogram to physically check their heart.

When Should Children Be Screened?

For children undergoing physical clinical screening, guidelines generally recommend starting between the ages of 10 and 12 ^[14][15]. The physical signs of HCM often emerge during periods of rapid growth, like puberty.

However, screening should be initiated at a younger age (under 10 years old) if:

• The child is experiencing concerning symptoms.
• The child is beginning intense or competitive athletic programs.
• There is a family history of early-onset HCM or sudden cardiac arrest ^[14][16].
• The family carries a known high-risk genetic variant ^[15][17].

Because HCM can develop later in life (age-related penetrance), children and adults who carry the gene or remain at risk due to family history must continue regular clinical check-ups over their lifetime ^[14][18]. A single normal echocardiogram in childhood does not mean they are clear of the disease forever ^[13][2].